Mydecine Announces First Quarter 2022 Financial Results and
DENVER, May 16, 2022 (GLOBE NEWSWIRE) -- Mydecine Innovations Group Inc. (NEO: MYCO) (OTC: MYCOF) (FSE: 0NFA) (“Mydecine” or the “Company”), a...
Source: globenewswire.com
Stay updated with breaking news from Cessation Study. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
DENVER, May 16, 2022 (GLOBE NEWSWIRE) -- Mydecine Innovations Group Inc. (NEO: MYCO) (OTC: MYCOF) (FSE: 0NFA) (“Mydecine” or the “Company”), a...